Exports of hormones recorded good growth in the first quarter

Exports of hormones recorded good growth in the first quarter

Exports of hormones recorded good growth in the first quarter

The export amount increased by 23.69% year-on-year, laying the foundation for export throughout the year

According to statistics from China Customs, in the first quarter of 2011, the export volume of hormonal APIs was 212.39 tons, an increase of 3.21% year-on-year; the export amount was US$147 million, an increase of 23.69% year-on-year, showing a good momentum of growth.

Various indicators increased year-on-year

China's hormonal APIs are mostly exported to Asia, Europe, Latin America and the EU, India, the United States, Mexico, Brazil and other countries and regions. In the first quarter of 2011, China's hormonal APIs exported 59.958 million U.S. dollars to Asia, an increase of 32.43% year-on-year; exports to Europe reached US$57.996 million, an increase of 20.62% over the same period of last year; and exports to North America accounted for US$ 15.5723 million, a year-on-year increase of 18.08% (Table 1). ). From a country point of view, exports to India were US$34.109 million, an increase of 36.71% year-on-year; exports to EU countries were US$49.2249 million, a year-on-year increase of 16.60%, and exports to the United States were US$14.134 million, a year-on-year increase of 27.06%.

China's major exporters of hormonal APIs are hydrocortisone, dexamethasone, estrogen and progesterone. According to statistics from China Customs, in the first quarter of 2011, the export of other female (scorpion) hormones and progesterone was US$50.1166 million, an increase of 31.37% over the same period of last year; cortisone, hydrocortisone, dehydrocortisone, and deshydrostannol. The export amount was 406.73 million US dollars, an increase of 43.33% over the same period of last year; the export amount of halogenated derivatives of other corticosteroid hormones was 204.838 million US dollars, an increase of 34.22% over the same period of last year (see Table 2).

In the first quarter of this year, there were 248 exporters of hormonal APIs. From the distribution of export companies by province and city, Zhejiang, Jiangsu, and Shanghai have a large number of export companies, ranking among the top three. Judging from the ranking of export value, Zhejiang, Tianjin and Jiangsu dominate. Tianjin Tianfa Pharmaceutical Import & Export Co., Ltd. ranked first in exports. Zhejiang Xianyu Pharmaceutical Co., Ltd., Henan Lihua Pharmaceutical Co., Ltd., and Changzhou Jiaerke Pharmaceutical Group Co., Ltd. ranked second, third, and third. Four, four companies accounted for 32.75% of the export value, which has a certain leading role in the market.

Reduced profit margins

In 2008, a sudden financial turmoil made the export of hormonal APIs in a downturn. After the crisis, with the continuous recovery of the international economy, China's exports of hormonal APIs showed a good growth trend. In the first quarter of this year, the export value increased by 23.69% year-on-year, which laid the foundation for the export growth for the whole year.

However, it must be mentioned that due to factors such as rising raw materials and changes in exchange rates in 2011, the operating profits of China's exporters of hormonal APIs will be squeezed. At the same time, the utilization of raw materials is low, energy consumption and environmental pollution, and byproducts Failure to effectively use such issues will still plague China's hormonal API manufacturers. (China Medical Insurance Association Du Hong)

Tablet Supplement

Tablet Supplement,Zinc Tablet,Buccal Tablet,Compound Vitamin B Tablet

Weihai Baihe Biology Technological Co., Ltd. , https://www.biohighnutraceutical.com

Posted on